Physician

Mohamad R El-Zaru, MD

According to 2025 Medicare claims, Mohamad El-Zaru, MD (NPI: 1366440794) practices interventional cardiology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is PONDVILLE CARDIOLOGY ASSOCIATES, LLC (NPI: 1205598224; TIN: 872882506) and primary practice location at 02062-1680. El-Zaru is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Mass General Brigham ACO, LLC (ACO ID: A4641), and Wellforce ACO, LLC (ACO ID: A4922), participating under the MSSP model.

El-Zaru's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 838 traditional Medicare patients, billed 4,744 HCPCS/CPT codes, and received $901,607 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 3,735 prescription claims across 550 beneficiaries totaling $1,107,532 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 104 claims. Open Payments data shows 118 records totaling $3,236. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $421,359 to $901,607. Similarly, Part D prescription costs have moved sharply higher in recent years, from $44,834 to $1,107,532. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	617	4,082	$421,359
2016	953	5,169	$456,681
2017	911	4,813	$409,415
2018	855	4,681	$870,547
2019	982	5,399	$1,438,118
2020	825	5,696	$1,377,260
2021	805	4,428	$1,080,203
2022	832	4,595	$1,038,080
2023	832	4,834	$923,147
2024	838	4,744	$901,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	206	1,499	$44,834
2016	283	2,231	$110,117
2017	366	2,480	$147,564
2018	372	2,891	$240,408
2019	378	2,948	$390,608
2020	416	3,301	$530,054
2021	430	3,141	$595,359
2022	458	3,099	$737,666
2023	493	3,313	$947,300
2024	550	3,735	$1,107,532

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	106	$10,965
2018	N/R	104	$5,619
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	132	136	$163
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	327	347	$162
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	637	1,359	$100
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	104	106	$56
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	600	908	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	439	26,779	$505,403
Xarelto	Rivaroxaban	117	7,630	$137,508
Entresto	Sacubitril/Valsartan	73	4,635	$97,876
Repatha Sureclick	Evolocumab	73	3,350	$64,259
Farxiga	Dapagliflozin Propanediol	48	2,700	$49,488

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$3,236	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamad R. El-Zaru, MD?

Tedicare shows public-source Medicare data for Mohamad R. El-Zaru, MD (NPI 1366440794), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamad R. El-Zaru, MD have ACO affiliation data?

Mohamad R. El-Zaru, MD is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Mass General Brigham ACO, LLC (MSSP, ACO ID A4641), and Wellforce ACO, LLC (MSSP, ACO ID A4922).

What billing organization is linked to Mohamad R. El-Zaru, MD?

Mohamad R. El-Zaru, MD is linked to PONDVILLE CARDIOLOGY ASSOCIATES, LLC (billing NPI 1205598224) in the available physician profile data.

Does Mohamad R. El-Zaru, MD have Open Payments data?

Mohamad R. El-Zaru, MD has 118 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.